Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of Thalamic Deep Brain Stimulation for the Treatment of Refractory Tourette Syndrome

NCT01817517 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT01817517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01817517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of Thalamic Deep Brain Stimulation for the Treatment of Refractory Tourette Syndrome
Lead sponsor
Johns Hopkins University
Phase
Not applicable
Overall status
Terminated
Start date
March 31, 2014
Completion date
February 2, 2023
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tourette syndrome